Study breakdown · Neurol Open Access, 2026

Three Midlife Risks, Thirteen Dementia‑Free Years

People who reached midlife without high blood pressure, diabetes, or current smoking lived about 13 more years without dementia than people who had all three. The gap is real. It is also not a promise that any one person can bank those years.

longtime.live 15 Aug 2026 8 min read Sources

12,409ARIC participants, mean age 56, dementia-free at baseline

26.3 yMedian follow-up into late life

3,008Developed dementia

5,238Died without dementia

Longevity writing often treats extra years as the prize. A new analysis in Neurology Open Access asks a sharper question: how many of those years are spent with a working brain?

Researchers led by Jiaqi Hu, with Josef Coresh of NYU Langone’s Optimal Aging Institute as senior investigator, used the long-running Atherosclerosis Risk in Communities (ARIC) study to estimate dementia-free survival from age 55 to 95. That is years lived both alive and without dementia. The outcome folds two risks together: getting dementia earlier, and dying earlier of something else.

The headline association, picked up by the NZ Herald and other outlets, is simple. People with none of three midlife vascular risks lived an average of 30.1 dementia-free years after 55. People with all three lived 17.5. The difference is 12.6 years, which coverage rounds to 13.

The three risks they counted

The team scored participants at a single midlife visit (1990–1992) on three factors that are both common and modifiable:

High blood pressure

Systolic 140 mm Hg or higher, diastolic 90 or higher, or blood-pressure medication.

Diabetes

A physician diagnosis, diabetes medication, or HbA1c of 6.5% or higher.

Current smoking

Self-reported current smoking. Former and never smokers were grouped together as the reference.

They chose this short list because the three were measured consistently in ARIC, raise both dementia and death risk, and had similar associations with dementia-free survival. The score is an unweighted count from 0 to 3, not a full cardiometabolic risk model.

Of the 12,409 people in the analysis, 5,271 had none of the three, 5,154 had one, 1,808 had two, and only 176 had all three. That last group is small, which is why its confidence interval is the widest.

Finding 1: the years fall in a straight line

From age 55, estimated dementia-free survival was:

12.6 extra dementia-free years for people with zero midlife risks versus all three, estimated between ages 55 and 95.

0 risks: 30.1 years (95% CI 29.9–30.4)
1 risk: 26.3 years (95% CI 26.1–26.6)
2 risks: 21.0 years (95% CI 20.5–21.4)
3 risks: 17.5 years (95% CI 16.3–18.7)

Each extra factor was worth roughly four fewer dementia-free years, which is the dose-response the Herald coverage emphasised. The paper’s own summary is more precise: optimal midlife vascular health was associated with up to 12.6 additional dementia-free survival years.

Restricted mean dementia-free survival between ages 55 and 95. These are modelled years in a competing-risk framework, not a guarantee for any one person. Hu et al., Neurol Open Access 2026;2:e000152.

Compared with people who had none of the three, those with all three had a 2.69-fold higher hazard of dementia (95% CI 1.94–3.73) and a 5.61-fold higher hazard of dying without dementia (95% CI 4.67–6.74), after adjustment for sex, education, race, physical activity, BMI, prior stroke, and APOE-ε4 status.

Finding 2: dying earlier is a large part of the story

This is the part most headlines skip, and it changes how you should read the 13 years.

People with more vascular risks got dementia earlier. They also died much earlier of heart disease, stroke, and other causes. Dementia incidence rose from 8.8 to 12.5 cases per 1,000 person-years across the four groups. Dementia-free death rose far more steeply, from 10.5 to 42.3 per 1,000.

That competing mortality produces a counterintuitive lifetime pattern. By age 75, cumulative dementia incidence was about 10% in the three-risk group versus 3% in the zero-risk group. By age 95, the zero-risk group had the highest lifetime dementia incidence (about 42%) because more of them were still alive to develop it. The three-risk group sat around 23%. They did not escape dementia. Many of them never reached the ages when it is most common.

By 85, only 7% of people with three risks were still alive and dementia-free (13 of 176), versus 35% of people with none (1,839 of 5,271). Among those who did develop dementia, survival afterward was short in every group: about 3.0 to 4.1 years. People with a heavier vascular burden therefore spent a larger share of their remaining life with dementia.

Heather Whitson, who was not involved in the study, put the patient-centred point cleanly in the Herald piece: people want to live longer, but nobody wants to outlive their brain. Dementia-free survival is the measure that tries to capture both.

The gap is not the same for everyone

The inverse relationship held across sex, race, and APOE-ε4 status. The starting points did not.

Women lived longer without dementia than men at every risk count. With all three factors, the estimates were 18.1 years for women and 16.6 years for men. Black participants had shorter dementia-free survival than White participants, and the gap widened as the risk count rose: 16.0 versus 19.6 years in the three-risk group. APOE-ε4 carriers also had fewer dementia-free years than non-carriers, though the vascular gradient still ran through both groups.

Coresh’s team notes that Black participants carried a higher midlife vascular burden, which likely explains part of the disparity. Vascular prevention may therefore matter most where the burden is already highest. That is a public-health argument, not a claim that biology is destiny.

Why heart risk shows up in the brain

The paper does not prove a mechanism. The biology it points to is familiar.

High blood pressure, diabetes, and smoking all damage blood vessels. Small-vessel injury starves brain tissue of oxygen and glucose and slows the clearance of waste. Larger hits become strokes, which raise dementia risk sharply on their own. Vessel damage also triggers inflammation that can fail to resolve, leaving plaque, poor healing, and more inflammation. Vascular disease may also speed the build-up of Alzheimer proteins such as amyloid.

In other words, the same midlife risks that cut life short also make the years you do get more likely to include cognitive decline. That is why the authors treat total vascular burden, not any one factor in isolation, as the useful frame.

What this study cannot tell you

Four caveats

It is observational. Nobody was assigned to avoid these risks. The paper can show a strong, graded association. It cannot prove that avoiding the three factors caused the extra dementia-free years.
Risks were measured once. A single midlife snapshot misses quitting smoking, new diabetes, or later blood-pressure treatment. The authors note this may underestimate the harm of risks that persist or worsen.
The three-risk group is small. Only 176 people had all three factors. The 17.5-year estimate is the least precise number on the chart.
The years are restricted means. The 12.6-year gap is an average between ages 55 and 95 in a competing-risk model. It is not 13 extra birthdays waiting for any one reader.

Residual confounding is also live. People with cleaner vascular profiles at 56 already differed in education, activity, BMI, and stroke history. The models adjust for those. They cannot adjust for everything.

What to take from it

Three things hold up well.

Midlife is not too late to matter, and not too early to start. The clock in this paper starts at 55. The risks were measured around then. Coresh’s public comment was that people should watch vascular health closely from the late forties. That matches a wider literature: blood pressure, glucose, and smoking in the 40s and 50s shape brain ageing decades later.

The useful target is years with a working brain, not dementia risk in isolation. Lifetime dementia incidence can look lower in the highest-risk group because death arrives first. Dementia-free survival is the measure that refuses that accounting trick.

The interventions are ordinary, not exotic. The American Heart Association’s Life’s Essential 8 still covers the ground: blood pressure, blood sugar, not smoking, a diet built on whole plant foods, and 150 minutes of moderate activity or 75 minutes of vigorous activity a week. The US POINTER trial also found that a structured lifestyle programme improved cognition in older adults already at risk of cognitive decline. That is a different design and a different age group, but it points the same way: the boring cardiovascular stack is brain policy.

If you already have high blood pressure, diabetes, or a smoking habit, the paper is not a verdict. It is a reason to treat those conditions as brain-protection work, not only heart-protection work, and to do that with a clinician who knows your history. Do not start, stop, or change medication from an article.

A 2025 Nature Medicine analysis from the same research circle estimated that about 42% of Americans may develop dementia after 55. Drug treatments for established disease remain limited. The ARIC result is one more argument that the largest lever still sits in midlife vessels.

Want a version of this arithmetic for your own habits? Our longevity calculator turns blood pressure, smoking, activity, and the rest into a life-expectancy estimate, with the assumptions shown.